OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2023
(6)
2022
(6)
2025
(5)
2021
(3)
2020
(2)
2019
(1)
2018
(1)
2017
(1)
2016
(1)
2015
(1)
2013
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
Not available
S-EPMC5984389
|
biostudies-literature
Cite
Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort.
Not available
S-EPMC10099832
|
biostudies-literature
Cite
In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening.
Not available
S-EPMC7149866
|
biostudies-literature
Cite
Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
Not available
S-EPMC8261295
|
biostudies-literature
Cite
Genomic landscape of pleural and peritoneal mesothelioma tumours.
Not available
S-EPMC9681755
|
biostudies-literature
Cite
CD26 as a potential therapeutic target for lung adenocarcinoma.
Not available
S-EPMC12711487
|
biostudies-literature
Cite
The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis.
Not available
S-EPMC7693632
|
biostudies-literature
Cite
Sotorasib for Lung Cancers with
KRAS
p.G12C Mutation.
Not available
S-EPMC9116274
|
biostudies-literature
Cite
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene.
Not available
S-EPMC9684265
|
biostudies-literature
Cite
Targeting ALK in Neuroendocrine Tumors of the Lung.
Not available
S-EPMC9214311
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets